Cancer Cell Membrane-Coated Gambogic Acid Nanoparticles for Effective Anticancer Vaccination by Activating Dendritic Cells
Fengli Huang,Qun Zhang,Jie Xiao,Xin Zhang,Xingzhi Han,Xiao Shi,Jing Hu,Li Li,Xiaoping Qian
DOI: https://doi.org/10.2147/IJN.S408521
IF: 7.033
2023-05-03
International Journal of Nanomedicine
Abstract:Fengli Huang, 1, &ast Qun Zhang, 2, &ast Jie Xiao, 3, &ast Xin Zhang, 1 Xingzhi Han, 3 Xiao Shi, 3 Jing Hu, 2 Li Li, 2 Xiaoping Qian 1, 2 1 Department of Oncology, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, People's Republic of China; 2 Department of Oncology, Nanjing Drum Tower Hospital, Nanjing, People's Republic of China; 3 Department of Oncology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, People's Republic of China &astThese authors contributed equally to this work Correspondence: Xiaoping Qian, Department of Oncology, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, 321 Zhongshan Road, Nanjing, Jiangsu, 210008, People's Republic of China, Tel +86-13951743162, Fax +86-25-68182342, Email Purpose: Recent studies have shown that traditional Chinese medicine (TCM), such as gambogic acid (GA), is involved in the regulation of tumor immune microenvironment and can be combined with other anti-tumor treatment strategies. Here, we used GA as an adjuvant to construct a nano-vaccine to improve the anti-tumor immune response of colorectal cancer (CRC). Materials and Methods: We used a previously reported two-step emulsification method to obtain poly (lactic-co-glycolic acid) /GA nanoparticles (PLGA/GA NPs), and then CT26 colon cancer cell membrane (CCM) was used to obtain CCM-PLGA/GA NPs. This novel nano-vaccine, CCM-PLGA/GA NPs, was co-synthesized with GA as an adjuvant and neoantigen provided by CT26 CCM. We further confirmed the stability, tumor targeting, and cytotoxicity of CCM-PLGA/GA NPs. The regulatory effect on the tumor immune microenvironment, the anti-tumor efficacy, and the combined anti-tumor efficacy with anti-PD-1 monoclonal Antibodies (mAbs) of this novel nano-vaccine was also detected in vivo. Results: We successfully constructed the CCM-PLGA/GA NPs. In vitro and in vivo tests showed low biological toxicity, as well as the high tumor-targeting ability of the CCM-PLGA/GA NPs. Besides, we revealed a remarkable effect of CCM-PLGA/GA NPs to activate the maturation of dendritic cells (DCs) and the formation of a positive anti-tumor immune microenvironment. Conclusion: This novel nano-vaccine constructed with GA as the adjuvant and CCM providing the tumor antigen can not only directly kill tumors by enhancing the ability of GA to target tumors, but also indirectly kill tumors by regulating tumor immune microenvironment, providing a new strategy for immunotherapy of CRC. Keywords: cancer immunotherapy, gambogic acid, nano-vaccine, tumor immune microenvironment, colorectal cancer Colorectal cancer (CRC) is one of the most common malignancies with high incidence and mortality. Although the prognosis of CRC patients has been improved, the 5-year survival rate of patients with advanced CRC is only approximately 10%. 1 Consequently, exploring new strategies for the treatment of advanced CRC remains significant and challenging. In recent years, immunotherapy has brought revolutionary changes to cancer therapy, including CRC. 2–4 The key to the success of immunotherapy is to rely on remodeling the positive tumor immune microenvironment to enhance the activation and killing of CD8-positive T cells. 5 According to recent studies, vascular endothelial growth factors (VEGF) signal is crucial to the tumor immune cycle and involved in tumor immune escape. 6,7 VEGF signal participates in regulating the immune function of the tumor microenvironment through a variety of mechanisms, 8,9 such as boosting the expression of IL-10, enhancing the differentiation towards M2-like macrophages, and inhibiting DC maturation, thereby reducing the activation of CD8 + T cells, which ultimately leads to the formation of tumor immunosuppressive microenvironment. 10 Recent studies have revealed that traditional Chinese medicine (TCM) can also synergize the efficacy of immunotherapy by modulating the immune microenvironment of tumors. 11 Gambogic acid (GA) is a TCM monomer extracted from the Garcinia hanburyi tree. It has been found that GA has strong anticancer activity against a variety of solid tumors including CRC. 12,13 Our previous studies revealed that GA exerts antitumor effects by counteracting VEGF-mediated angiogenesis, 14 suggesting its potential to modulate the tumor immune microenvironment. 15 Nevertheless, the poor water solubility and toxic side effects of GA restricted its clinical application. 12 -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology